Cannabics Pharmaceuticals, a company developing a platform that leverages novel drug-screening tools and artificial intelligence to create customized cannabinoid-based cancer therapies, published the final results of a pilot study that could potentially treat a common complication of cancer using the company’s dosage-controlled cannabis capsules in the Journal of Integrative Cancer Therapies, the company announced last […]